Marla Jalbut

Marla Jalbut, MD, MBA, currently serves as a Board Observer at Rectify Pharma and as an Investment Associate at Omega Funds, both since October 2023. In parallel, Marla is an Attending Physician in the Hospital Medicine Unit at Massachusetts General Hospital and an Instructor at Harvard Medical School, positions held since July 2022. Previous experience includes residency at Yale New Haven Hospital in Internal Medicine, and advisory roles in a biotech firm. Research contributions span clinical studies in acute myeloid leukemia with a grant from the American Cancer Society and biochemical investigations at Princeton University. Marla holds an MBA from Harvard Business School, an MD from Tufts University School of Medicine, and a BA in Chemistry, Global Health and Health Policy from Princeton University.